KALV
KalVista Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Edward P. Feener sold $123K of KalVista Pharmaceuticals, Inc.
Sold$123,134
$20.52Price
6,000Shares
−42%Stake
What KALV did after the filing
Prices for KALV after this filing aren't in yet.
Traded Mon, Aug 2. Filed Wed, Aug 4, 3:55 PM ET, during the session. Not investment advice.